Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
20.61B | 21.15B | 19.58B | 19.54B | 18.83B | 18.33B | Gross Profit |
15.42B | 15.79B | 14.76B | 14.84B | 14.34B | 14.11B | EBIT |
606.15M | 459.63M | 552.27M | 803.96M | 679.93M | 611.92M | EBITDA |
849.12M | 1.27B | 1.02B | 1.25B | 918.79M | 990.51M | Net Income Common Stockholders |
198.55M | 254.16M | 225.27M | 514.14M | 423.42M | 121.81M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.17B | 2.12B | 2.56B | 2.56B | 5.29B | 7.28B | Total Assets |
19.61B | 20.20B | 22.02B | 18.05B | 17.34B | 18.01B | Total Debt |
1.82B | 1.54B | 3.67B | 175.36M | 125.93M | 732.95M | Net Debt |
657.00M | -586.00M | 1.10B | -2.38B | -5.16B | -6.55B | Total Liabilities |
5.43B | 5.57B | 7.46B | 3.80B | 3.55B | 4.65B | Stockholders Equity |
14.18B | 14.63B | 14.56B | 14.25B | 13.80B | 13.36B |
Cash Flow | Free Cash Flow | ||||
0.00 | 1.43B | -1.15B | -802.37M | -298.09M | 2.41B | Operating Cash Flow |
0.00 | 1.71B | -849.03M | -264.54M | 101.72M | 2.94B | Investing Cash Flow |
0.00 | 442.01M | -2.41B | -2.23B | -1.29B | -1.00B | Financing Cash Flow |
0.00 | -2.60B | 3.27B | -239.05M | -782.97M | 424.17M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥6.15B | 7.29 | 3.33% | -9.85% | -8.43% | ||
79 Outperform | ¥8.61B | 5.92 | 2.56% | 1.86% | -13.39% | ||
76 Outperform | ¥7.91B | 33.12 | 3.12% | -3.35% | -41.42% | ||
68 Neutral | ¥8.71B | 21.19 | 7.67% | -6.22% | -84.84% | ||
68 Neutral | ¥8.91B | 35.04 | 1.14% | 8.01% | 12.92% | ||
62 Neutral | $6.86B | 11.07 | 2.77% | 4.27% | 2.66% | -24.95% | |
53 Neutral | ¥6.14B | ― | 2.06% | -12.30% | -274.20% |